Odyssey Health, Inc. (ODYY) stock
ODYYOTCSurgical & Medical Instruments & ApparatusFiscal year ends July 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 0/30
$0.01−0.00 (-16.25%)
Close on Oct 19, 2026Market cap $746.34KP/E –Yield –
Odyssey Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Odyssey Health's ebitda for the twelve months ending Apr 30, 2025 was -$627.64K. For fiscal 2024 it was -$2.14M. The highest annual figure on record is -$68.43K in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | -$2.14M | – |
| FY2023 | Jul 31, 2023 | -$5.31M | – |
| FY2022 | Jul 31, 2022 | -$8.10M | – |
| FY2021 | Jul 31, 2021 | -$15.86M | – |
| FY2020 | Jul 31, 2020 | -$3.84M | – |
| FY2019 | Jul 31, 2019 | -$23.57M | – |
| FY2018 | Jul 31, 2018 | -$409.89K | – |
| FY2017 | Jul 31, 2017 | -$157.02K | – |
| FY2016 | Jul 31, 2016 | -$68.43K | – |
| FY2015 | Jul 31, 2015 | -$155.90K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | -$129.06K | – |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | -$156.59K | – |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | -$579.43K | – |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $237.43K | – |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | -$372.37K | – |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | -$1.16M | – |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | -$346.30K | – |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | -$654.22K | – |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | -$1.09M | – |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | -$1.49M | – |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | -$2.08M | – |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | -$1.83M | – |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | -$2.87M | – |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | -$1.98M | – |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | -$1.43M | – |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | -$2.61M | – |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | -$12.09M | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | -$631.15K | – |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | -$522.63K | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | -$1.15M | – |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | -$865.03K | – |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | -$497.12K | – |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | -$1.32M | – |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | -$23.39M | – |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | -$42.55K | – |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | -$87.13K | – |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | -$49.77K | – |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | -$79.15K | – |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | -$54.76K | – |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | -$229.12K | – |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | -$46.86K | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | -$50.60K | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | -$69.76K | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | -$23.39K | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | -$13.27K | – |
See a number that looks wrong?